{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T14:04:52Z","timestamp":1787321092320,"version":"build-2736575974"},"reference-count":74,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T00:00:00Z","timestamp":1745280000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC-112-2320-B-007-010"],"award-info":[{"award-number":["NSTC-112-2320-B-007-010"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC-113-2311-B-007-008"],"award-info":[{"award-number":["NSTC-113-2311-B-007-008"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Microbiology, Immunology and Infection"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jmii.2025.04.003","type":"journal-article","created":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T12:08:51Z","timestamp":1745410131000},"page":"623-631","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Therapeutic application of regulatory T cell in osteoarthritis"],"prefix":"10.1016","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1028-4732","authenticated-orcid":false,"given":"Wan-Chen","family":"Hsieh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzu-Sheng","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuan-Wen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3237-4803","authenticated-orcid":false,"given":"Ming-Zong","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.jmii.2025.04.003_bib1","doi-asserted-by":"crossref","first-page":"e508","DOI":"10.1016\/S2665-9913(23)00163-7","article-title":"Global, regional, and national burden of osteoarthritis, 1990-2020 and projections to 2050: a systematic analysis for the Global Burden of Disease Study 2021","volume":"5","author":"Collaborators","year":"2023","journal-title":"Lancet Rheumatol"},{"issue":"6","key":"10.1016\/j.jmii.2025.04.003_bib2","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1001\/jama.2020.22171","article-title":"Diagnosis and treatment of hip and knee osteoarthritis: a review","volume":"325","author":"Katz","year":"2021","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.jmii.2025.04.003_bib3","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.joca.2022.11.005","article-title":"Pharmaceutical treatment of osteoarthritis","volume":"31","author":"Richard","year":"2023","journal-title":"Osteoarthr Cartil"},{"issue":"10","key":"10.1016\/j.jmii.2025.04.003_bib4","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/j.joca.2023.05.015","article-title":"Recommendations for the management of hip and knee osteoarthritis: a systematic review of clinical practice guidelines","volume":"31","author":"Gibbs","year":"2023","journal-title":"Osteoarthr Cartil"},{"issue":"11","key":"10.1016\/j.jmii.2025.04.003_bib5","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/nrrheum.2010.159","article-title":"The role of synovitis in pathophysiology and clinical symptoms of osteoarthritis","volume":"6","author":"Sellam","year":"2010","journal-title":"Nat Rev Rheumatol"},{"issue":"5","key":"10.1016\/j.jmii.2025.04.003_bib6","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/s41584-022-00749-9","article-title":"Synovial inflammation in osteoarthritis progression","volume":"18","author":"Sanchez-Lopez","year":"2022","journal-title":"Nat Rev Rheumatol"},{"issue":"4","key":"10.1016\/j.jmii.2025.04.003_bib7","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/nrd1693","article-title":"Osteoarthritis - an untreatable disease?","volume":"4","author":"Wieland","year":"2005","journal-title":"Nat Rev Drug Discov"},{"issue":"4","key":"10.1016\/j.jmii.2025.04.003_bib8","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.joca.2023.12.005","article-title":"Inflammation in osteoarthritis: our view on its presence and involvement in disease development over the years","volume":"32","author":"van den Bosch","year":"2024","journal-title":"Osteoarthr Cartil"},{"issue":"2","key":"10.1016\/j.jmii.2025.04.003_bib9","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.immuni.2023.01.004","article-title":"Principles of regulatory T cell function","volume":"56","author":"Dikiy","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.jmii.2025.04.003_bib10","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.3389\/fimmu.2018.01048","article-title":"Foxp3(+) T regulatory cells: still many unanswered questions-A perspective after 20 Years of study","volume":"9","author":"Shevach","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jmii.2025.04.003_bib11","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1146\/annurev-immunol-042718-041717","article-title":"Regulatory T cells and human disease","volume":"38","author":"Sakaguchi","year":"2020","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jmii.2025.04.003_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2022.102986","article-title":"Engineered Treg cells: the heir to the throne of immunotherapy","volume":"144","author":"Stucchi","year":"2024","journal-title":"J Autoimmun"},{"issue":"10","key":"10.1016\/j.jmii.2025.04.003_bib13","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/nrrheum.2016.136","article-title":"Low-grade inflammation as a key mediator of the pathogenesis of osteoarthritis","volume":"12","author":"Robinson","year":"2016","journal-title":"Nat Rev Rheumatol"},{"issue":"7","key":"10.1016\/j.jmii.2025.04.003_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10071604","article-title":"The involvement of neutrophils in the pathophysiology and treatment of osteoarthritis","volume":"10","author":"Chaney","year":"2022","journal-title":"Biomedicines"},{"issue":"5","key":"10.1016\/j.jmii.2025.04.003_bib15","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1186\/ar2502","article-title":"Immune regulation of bone loss by Th17 cells","volume":"10","author":"Adamopoulos","year":"2008","journal-title":"Arthritis Res Ther"},{"issue":"10","key":"10.1016\/j.jmii.2025.04.003_bib16","doi-asserted-by":"crossref","first-page":"5493","DOI":"10.1172\/JCI134091","article-title":"IL-17 and immunologically induced senescence regulate response to injury in osteoarthritis","volume":"130","author":"Faust","year":"2020","journal-title":"J Clin Investig"},{"key":"10.1016\/j.jmii.2025.04.003_bib17","first-page":"356","article-title":"T cells in osteoarthritis: alterations and beyond","volume":"8","author":"Li","year":"2017","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.jmii.2025.04.003_bib18","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13075-020-02410-w","article-title":"Proinflammatory T cell polarization is already present in patients with early knee osteoarthritis","volume":"23","author":"Rosshirt","year":"2021","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"10.1016\/j.jmii.2025.04.003_bib19","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/1440-1681.12567","article-title":"Circulating T helper 9 cells and increased serum interleukin-9 levels in patients with knee osteoarthritis","volume":"43","author":"Qi","year":"2016","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"11","key":"10.1016\/j.jmii.2025.04.003_bib20","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1016\/j.joca.2014.12.007","article-title":"Differential expression of interleukin-17 and interleukin-22 in inflamed and non-inflamed synovium from osteoarthritis patients","volume":"23","author":"Deligne","year":"2015","journal-title":"Osteoarthr Cartil"},{"issue":"8","key":"10.1016\/j.jmii.2025.04.003_bib21","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/joor.12649","article-title":"Th1\/Th17\/Th22 immune response and their association with joint pain, imagenological bone loss, RANKL expression and osteoclast activity in temporomandibular joint osteoarthritis: a preliminary report","volume":"45","author":"Monasterio","year":"2018","journal-title":"J Oral Rehabil"},{"issue":"9","key":"10.1016\/j.jmii.2025.04.003_bib22","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.joca.2023.06.002","article-title":"B cells in osteoarthritis: simply a sign or a target for therapy?","volume":"31","author":"Burt","year":"2023","journal-title":"Osteoarthr Cartil"},{"issue":"9","key":"10.1016\/j.jmii.2025.04.003_bib23","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.joca.2023.03.017","article-title":"B-cell capacity for expansion and differentiation into plasma cells are altered in osteoarthritis","volume":"31","author":"Xie","year":"2023","journal-title":"Osteoarthr Cartil"},{"issue":"7","key":"10.1016\/j.jmii.2025.04.003_bib24","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/s41577-024-00994-x","article-title":"The regulation and differentiation of regulatory T cells and their dysfunction in autoimmune diseases","volume":"24","author":"Sumida","year":"2024","journal-title":"Nat Rev Immunol"},{"issue":"11","key":"10.1016\/j.jmii.2025.04.003_bib25","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1016\/j.immuni.2022.10.006","article-title":"Regulatory T cells as metabolic sensors","volume":"55","author":"de Candia","year":"2022","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.jmii.2025.04.003_bib26","article-title":"Treg-tissue cell interactions in repair and regeneration","volume":"221","author":"Loffredo","year":"2024","journal-title":"J Exp Med"},{"issue":"2","key":"10.1016\/j.jmii.2025.04.003_bib27","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1093\/cei\/uxac123","article-title":"Treg specialization and functions beyond immune suppression","volume":"211","author":"Astarita","year":"2023","journal-title":"Clin Exp Immunol"},{"issue":"14","key":"10.1016\/j.jmii.2025.04.003_bib28","doi-asserted-by":"crossref","DOI":"10.1172\/JCI170505","article-title":"Differential roles of regulatory T cells in acute respiratory infections","volume":"133","author":"Jovisic","year":"2023","journal-title":"J Clin Investig"},{"key":"10.1016\/j.jmii.2025.04.003_bib29","doi-asserted-by":"crossref","first-page":"585","DOI":"10.3389\/fimmu.2018.00585","article-title":"Regulatory T-cells: potential regulator of tissue repair and regeneration","volume":"9","author":"Li","year":"2018","journal-title":"Front Immunol"},{"issue":"315","key":"10.1016\/j.jmii.2025.04.003_bib30","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aad4134","article-title":"Type 1 diabetes immunotherapy using polyclonal regulatory T cells","volume":"7","author":"Bluestone","year":"2015","journal-title":"Sci Transl Med"},{"issue":"746","key":"10.1016\/j.jmii.2025.04.003_bib31","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adn2404","article-title":"A phase 2 randomized trial with autologous polyclonal expanded regulatory T cells in children with new-onset type 1 diabetes","volume":"16","author":"Bender","year":"2024","journal-title":"Sci Transl Med"},{"issue":"10237","key":"10.1016\/j.jmii.2025.04.003_bib32","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/S0140-6736(20)30167-7","article-title":"Regulatory cell therapy in kidney transplantation (The ONE Study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1\/2A trials","volume":"395","author":"Sawitzki","year":"2020","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.jmii.2025.04.003_bib33","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1182\/blood-2015-06-653667","article-title":"Umbilical cord blood-derived T regulatory cells to prevent GVHD: kinetics, toxicity profile, and clinical effect","volume":"127","author":"Brunstein","year":"2016","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.jmii.2025.04.003_bib34","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41573-024-01089-x","article-title":"Harnessing the biology of regulatory T cells to treat disease","volume":"24","author":"Wardell","year":"2025","journal-title":"Nat Rev Drug Discov"},{"issue":"10","key":"10.1016\/j.jmii.2025.04.003_bib35","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/s41577-022-00680-w","article-title":"Engineering IL-2 for immunotherapy of autoimmunity and cancer","volume":"22","author":"Hernandez","year":"2022","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jmii.2025.04.003_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.744763","article-title":"Polyclonal regulatory T cell manufacturing under cGMP: a decade of experience","volume":"12","author":"Balcerek","year":"2021","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.jmii.2025.04.003_bib37","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s00125-023-06076-2","article-title":"Genetic engineering of regulatory T cells for treatment of autoimmune disorders including type 1 diabetes","volume":"67","author":"Tuomela","year":"2024","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.jmii.2025.04.003_bib38","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.it.2023.11.005","article-title":"Chimeric antigen receptor T(reg) therapy in transplantation","volume":"45","author":"Eskandari","year":"2024","journal-title":"Trends Immunol"},{"issue":"3","key":"10.1016\/j.jmii.2025.04.003_bib39","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41577-019-0232-6","article-title":"T(reg) cell-based therapies: challenges and perspectives","volume":"20","author":"Raffin","year":"2020","journal-title":"Nat Rev Immunol"},{"issue":"557","key":"10.1016\/j.jmii.2025.04.003_bib40","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaz3866","article-title":"Functional effects of chimeric antigen receptor co-receptor signaling domains in human regulatory T cells","volume":"12","author":"Dawson","year":"2020","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jmii.2025.04.003_bib41","article-title":"Metallothionein-1 mitigates the advancement of osteoarthritis by regulating Th17\/Treg balance","volume":"405\u2013406","author":"Xia","year":"2024","journal-title":"Cell Immunol"},{"issue":"10","key":"10.1016\/j.jmii.2025.04.003_bib42","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1089\/dna.2017.3771","article-title":"Overexpression of lymphocyte activation gene-3 inhibits regulatory T cell responses in osteoarthritis","volume":"36","author":"Xia","year":"2017","journal-title":"DNA Cell Biol"},{"issue":"1","key":"10.1016\/j.jmii.2025.04.003_bib43","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s10020-021-00315-1","article-title":"MiR-206 regulates the Th17\/Treg ratio during osteoarthritis","volume":"27","author":"Ye","year":"2021","journal-title":"Mol Med"},{"issue":"4","key":"10.1016\/j.jmii.2025.04.003_bib44","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1177\/03635465231153588","article-title":"T helper 17-like regulatory T cells in equine synovial fluid are associated with disease severity of naturally occurring posttraumatic osteoarthritis","volume":"51","author":"Keller","year":"2023","journal-title":"Am J Sports Med"},{"key":"10.1016\/j.jmii.2025.04.003_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.tice.2022.101906","article-title":"Max interacting protein 1 induces IL-17-producing T helper\/regulatory T imbalance in osteoarthritis by upregulating tectonic family member 2","volume":"78","author":"Li","year":"2022","journal-title":"Tissue Cell"},{"key":"10.1016\/j.jmii.2025.04.003_bib46","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.biopha.2016.01.036","article-title":"Downregulation of IL-10 secretion by Treg cells in osteoarthritis is associated with a reduction in Tim-3 expression","volume":"79","author":"Li","year":"2016","journal-title":"Biomed Pharmacother"},{"issue":"9","key":"10.1016\/j.jmii.2025.04.003_bib47","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10092111","article-title":"Infiltration profile of regulatory T cells in osteoarthritis-related pain and disability","volume":"10","author":"Nees","year":"2022","journal-title":"Biomedicines"},{"issue":"12","key":"10.1016\/j.jmii.2025.04.003_bib48","doi-asserted-by":"crossref","first-page":"4104","DOI":"10.1002\/art.23138","article-title":"Treg cells suppress osteoclast formation: a new link between the immune system and bone","volume":"56","author":"Zaiss","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.jmii.2025.04.003_bib49","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1002\/art.27535","article-title":"Increased bone density and resistance to ovariectomy-induced bone loss in FoxP3-transgenic mice based on impaired osteoclast differentiation","volume":"62","author":"Zaiss","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.jmii.2025.04.003_bib50","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1111\/apm.12706","article-title":"STAT3 promotes bone fracture healing by enhancing the FOXP3 expression and the suppressive function of regulatory T cells","volume":"125","author":"Sun","year":"2017","journal-title":"Apmis"},{"issue":"12","key":"10.1016\/j.jmii.2025.04.003_bib51","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1002\/art.41051","article-title":"Contribution of inflammation and bone destruction to pain in arthritis: a study in murine glucose-6-phosphate isomerase-induced arthritis","volume":"71","author":"Ebbinghaus","year":"2019","journal-title":"Arthritis Rheumatol"},{"issue":"8","key":"10.1016\/j.jmii.2025.04.003_bib52","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1038\/nm.4373","article-title":"Resolution of inflammation by interleukin-9-producing type 2 innate lymphoid cells","volume":"23","author":"Rauber","year":"2017","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.jmii.2025.04.003_bib53","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1007\/s11684-023-1024-8","article-title":"A distinct \"repair\" role of regulatory T cells in fracture healing","volume":"18","author":"Wu","year":"2024","journal-title":"Front Med"},{"key":"10.1016\/j.jmii.2025.04.003_bib54","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2024.1341002","article-title":"An exploration of the causal relationship between 731 immunophenotypes and osteoporosis: a bidirectional Mendelian randomized study","volume":"15","author":"Zhou","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"10.1016\/j.jmii.2025.04.003_bib55","doi-asserted-by":"crossref","DOI":"10.1172\/JCI180679","article-title":"Progranulin-dependent repair function of regulatory T cells drives bone-fracture healing","volume":"135","author":"Chen","year":"2024","journal-title":"J Clin Investig"},{"issue":"8","key":"10.1016\/j.jmii.2025.04.003_bib56","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1097\/j.pain.0000000000001879","article-title":"Regulatory T cells counteract neuropathic pain through inhibition of the Th1 response at the site of peripheral nerve injury","volume":"161","author":"Davoli-Ferreira","year":"2020","journal-title":"Pain"},{"issue":"34","key":"10.1016\/j.jmii.2025.04.003_bib57","doi-asserted-by":"crossref","first-page":"17045","DOI":"10.1073\/pnas.1902091116","article-title":"TNFR2 promotes Treg-mediated recovery from neuropathic pain across sexes","volume":"116","author":"Fischer","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"47","key":"10.1016\/j.jmii.2025.04.003_bib58","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abo5284","article-title":"Tolerogenic nanoparticles induce type II collagen-specific regulatory T cells and ameliorate osteoarthritis","volume":"8","author":"Sohn","year":"2022","journal-title":"Sci Adv"},{"issue":"1","key":"10.1016\/j.jmii.2025.04.003_bib59","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/s13075-024-03417-3","article-title":"Small heterodimer partner-interacting leucine zipper protein suppresses pain and cartilage destruction in an osteoarthritis model by modulating the AMPK\/STAT3 signaling pathway","volume":"26","author":"Moon","year":"2024","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"10.1016\/j.jmii.2025.04.003_bib60","doi-asserted-by":"crossref","first-page":"156","DOI":"10.15252\/embr.201744421","article-title":"Regulatory T cells are expanded by Teriparatide treatment in humans and mediate intermittent PTH-induced bone anabolism in mice","volume":"19","author":"Yu","year":"2018","journal-title":"EMBO Rep"},{"issue":"1","key":"10.1016\/j.jmii.2025.04.003_bib61","doi-asserted-by":"crossref","first-page":"7863","DOI":"10.1038\/s41467-024-51353-2","article-title":"Local administration of regulatory T cells promotes tissue healing","volume":"15","author":"Nayer","year":"2024","journal-title":"Nat Commun"},{"issue":"769","key":"10.1016\/j.jmii.2025.04.003_bib62","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adj9331","article-title":"Human OX40L-CAR-T(regs) target activated antigen-presenting cells and control T cell alloreactivity","volume":"16","author":"Rui","year":"2024","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jmii.2025.04.003_bib63","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/978-1-0716-3593-3_15","article-title":"Redirecting human conventional and regulatory T cells using chimeric antigen receptors","volume":"2748","author":"Zimmerman","year":"2024","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.jmii.2025.04.003_bib64","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.omtm.2020.11.008","article-title":"Genetic engineering of human and mouse CD4+ and CD8+ Tregs using lentiviral vectors encoding chimeric antigen receptors","volume":"20","author":"Vimond","year":"2020","journal-title":"Mol Ther Methods Clin Dev"},{"key":"10.1016\/j.jmii.2025.04.003_bib65","article-title":"Generation of human chimeric antigen receptor regulatory T cells","volume":"215","author":"Cochrane","year":"2025","journal-title":"J Vis Exp"},{"key":"10.1016\/j.jmii.2025.04.003_bib66","article-title":"CD39 delineates chimeric antigen receptor regulatory T cell subsets with distinct cytotoxic & regulatory functions against human islets","volume":"15","author":"Wu","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.jmii.2025.04.003_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2023.103057","article-title":"Supraphysiological FOXP3 expression in human CAR-Tregs results in improved stability, efficacy, and safety of CAR-Treg products for clinical application","volume":"138","author":"Henschel","year":"2023","journal-title":"J Autoimmun"},{"issue":"7","key":"10.1016\/j.jmii.2025.04.003_bib68","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S1474-4422(23)00194-1","article-title":"Safety and clinical activity of autologous RNA chimeric antigen receptor T-cell therapy in myasthenia gravis (MG-001): a prospective, multicentre, open-label, non-randomised phase 1b\/2a study","volume":"22","author":"Granit","year":"2023","journal-title":"Lancet Neurol"},{"issue":"7971","key":"10.1016\/j.jmii.2025.04.003_bib69","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/s41586-023-06243-w","article-title":"CAR T therapy beyond cancer: the evolution of a living drug","volume":"619","author":"Baker","year":"2023","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.jmii.2025.04.003_bib70","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/nm.3432","article-title":"Pathogenic conversion of Foxp3+ T cells into TH17 cells in autoimmune arthritis","volume":"20","author":"Komatsu","year":"2014","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.jmii.2025.04.003_bib71","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/s41467-018-02862-4","article-title":"IL-6 receptor blockade corrects defects of XIAP-deficient regulatory T cells","volume":"9","author":"Hsieh","year":"2018","journal-title":"Nat Commun"},{"issue":"14","key":"10.1016\/j.jmii.2025.04.003_bib72","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2219086120","article-title":"Tonic-signaling chimeric antigen receptors drive human regulatory T cell exhaustion","volume":"120","author":"Lamarche","year":"2023","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.jmii.2025.04.003_bib73","doi-asserted-by":"crossref","first-page":"e212","DOI":"10.1016\/S2665-9913(24)00240-6","article-title":"Barriers to CAR T-cell therapy in rheumatology","volume":"7","author":"Lungova","year":"2025","journal-title":"Lancet Rheumatol"},{"issue":"6","key":"10.1016\/j.jmii.2025.04.003_bib74","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.stem.2024.05.004","article-title":"Human iPSC-derived CD4(+) Treg-like cells engineered with chimeric antigen receptors control GvHD in a xenograft model","volume":"31","author":"Yano","year":"2024","journal-title":"Cell Stem Cell"}],"container-title":["Journal of Microbiology, Immunology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118225000830?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118225000830?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T20:32:59Z","timestamp":1765485179000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1684118225000830"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":74,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S1684118225000830"],"URL":"https:\/\/doi.org\/10.1016\/j.jmii.2025.04.003","relation":{},"ISSN":["1684-1182"],"issn-type":[{"value":"1684-1182","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic application of regulatory T cell in osteoarthritis","name":"articletitle","label":"Article Title"},{"value":"Journal of Microbiology, Immunology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmii.2025.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}